NBTX
NanobiotixNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
Factor tilt: Momentum-tilted Small Cap
$21.49-8.16%
Close Oct 13, 2026
- Market cap
- $1.03B
- 1 month
- -39.9%
- 3 months
- -46.2%
- 1 year
- -8.9%
- 52-week range
- $15.08$55.07
- Dividend
- No dividends on record
- Short interest
- 0.4% of float146.9K shares · settled Sep 30, 2026 · -16.5% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if NBTX is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: HIGH
5 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
19 filers reported a long position in NBTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| JOHNSON & JOHNSON | $212M | 5.6M | Unchanged |
| MORGAN STANLEY | $1.9M | 49.8K | +37.3% |
| JANE STREET GROUP, LLC | $1.2M | 32.2K | New |
| HRT FINANCIAL LP | $1M | 27.3K | New |
| XTX Topco Ltd | $597.7K | 15.9K | New |
| Optiver Holding B.V. | $513.9K | 13.6K | +1% |
| MARSHALL WACE, LLP | $378.7K | 10K | +8.7% |
| CITADEL ADVISORS LLC | $227.8K | 6K | New |
| BNP PARIBAS FINANCIAL MARKETS | $152.5K | 4K | +13.6% |
| UBS Group AG | $97.2K | 2.6K | -53.6% |
Get the Full Analysis for NBTX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.